Guangshengtang: There have been no major changes in the company's fundamentals, and there may be a risk of the stock price falling after a sharp increase.

Guangshengtang announced on the evening of July 31st that the company's stock had a deviation exceeding 30% in the closing prices for three consecutive trading days from July 29th to July 31st, 2025. According to the rules of the Shenzhen Stock Exchange, this situation constitutes abnormal fluctuations in stock trading. According to the latest data from China Securities Index Co., Ltd., as of July 30th, 2025, the company's latest price-to-book ratio is 46.58; the latest price-to-book ratio for the industry category "pharmaceutical manufacturing" that the company belongs to is 3.17. There is a significant discrepancy between the company's price-to-book ratio and that of its industry peers. The company's stock price has risen significantly in the short term, but there have been no major changes in the company's fundamentals. There may be a risk of a sharp decline in the stock price after the significant rise. We solemnly remind investors to pay attention to the risks of trading in the company's stock secondary market, make rational decisions, and invest cautiously.